The role of the blood-brain barrier transporter PTS-1 in regulating concentrations of methionine enkephalin in blood and brain

Alcohol

Volumn 14, Issue 3, 1997, Pages 237-245

  Banks, William A ^a,b   Kastin, Abba J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Addiction; Blood brain barrier; Efflux; Genetic peptide; Methionine enkephalin; PTS 1

Indexed keywords

ALCOHOL; BRAIN PEPTIDE; METENKEPHALIN; NEUROPEPTIDE;

ADDICTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD LEVEL; BRAIN LEVEL; EFFUSION; IMMUNOREACTIVITY; MOUSE; NONHUMAN; REGULATORY MECHANISM;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; ENKEPHALIN, METHIONINE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED STRAINS;

ANIMALIA;

EID: 0030990769     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-8329(96)00148-6     Document Type: Article

References (31)

1. Banks, W. A.; Kastin, A. J.: Aging and the blood-brain barrier: Changes in the carrier-mediated transport of peptides in rats. Neurosci. Lett. 61:171-175; 1985.
2. Banks, W. A.; Kastin, A. J.: Modulation of the carrier-mediated transport of the Tyr-MIF-1 across the blood-brain barrier by essential amino acids. J. Pharmacol. Exp. Ther. 239:668-672; 1986.
3. Banks, W. A.; Kastin, A. J.: Twenty-one hormones fail to inhibit the brain to blood transport system for Tyr-MIF-1 and the enkephalins in mice. J. Pharm. Pharmacol. 40:289-291; 1988.
4. Banks, W. A.; Kastin, A. J.: Effect of neurotransmitters on the system that transports Tyr-MIF-1 and the enkephalins across the blood-brain barrier: A dominant role for serotonin. Psychopharmacology (Berlin) 98:380-385; 1989.
5. Banks, W. A.; Kastin, A. J.: Inhibition of the brain to blood transport system for enkephalins and Tyr-MIF-1 in mice addicted or genetically predisposed to drinking ethanol. Alcohol 6:53-57; 1989.
6. Banks, W. A.; Kastin, A. J.: Quantifying carrier-mediated transport of peptides from the brain to the blood. In: Conn P. M., ed. Methods in enzymology, vol. 168. San Diego: Academic Press: 1989:652-660.
7. Banks, W. A.; Kastin, A. J.: Editorial review: Peptide transport systems for opiates across the blood-brain barrier. Am. J. Physiol. 259:E1-E10; 1990.
8. Banks, W. A.; Kastin, A. J.: The potential for alcohol to affect the passage of peptide and protein hormones across the blood-brain barrier: A hypothesis for a disturbance in brain-body communication. In: Zakhari, S., ed. NIAAA Research Monograph 23, Alcohol and the Endocrine System. Bethesda, MD: National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism; 1993:401-411.
9. Banks, W. A.; Kastin, A. J.: Brain-to-blood transport of peptides and the alcohol withdrawal syndrome. In: Strand, F. L.; Beckwith, B.; Chronwall, B.; Sandman, C. A., eds. Models of neuropeptide action. New York: New York Academy of Sciences; 1994:108-118.
10. 2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1. J. Neurosci. Res. 35:690-695; 1993.
11. Banks, W. A.; Kastin, A. J.; Fasold, M. B.: Differential effect of aluminum on the blood-brain barrier transport of peptides, technetium and albumin. J. Pharmacol. Exp. Ther. 244:579-585; 1988.
12. Banks, W. A.; Kastin, A. J.; Fischman, A. J.; Coy, D. H.; Strauss, S. L.: Carrier-mediated transport of enkephalins and N-Tyr-MIF-1 across blood-brain barrier. Am. J. Physiol. 251:E477-E482; 1986.
13. Banks, W. A.; Kastin, A. J.; Horvath, A.; Michals, E. A.: Carrier-mediated transport of vasopressin across the blood-brain barrier of the mouse. J. Neurosci. Res. 18:326-332; 1987.
14. 1-38 across the blood-brain barrier. J. Pharmacol. Exp. Ther. 267:690-696; 1993.
15. Banks, W. A.; Kastin, A. J.; Michals, E. A.: Tyr-MIF-1 and metenkephalin share a saturable blood-brain barrier transport system. Peptides 8:899-903; 1987.
16. Banks, W. A.; Kastin, A. J.; Michals, E. A.; Barrera, C. M.: Stereospecific transport of Tyr-MIF-1 across the blood-brain barrier by peptide transport system-1. Brain Res. Bull. 25:589-592; 1990.
17. Banks, W. A.; Schally, A. V.; Barrera, C. M.; Fasold, M. B.; Durham, D. A.; Csernus, V. J., Groot, K.; Kastin, A. J.: Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin. Proc. Natl. Acad. Sci. USA 87:6762-6766; 1990.
18. Barrera, C. M.; Banks, W. A.; Kastin, A. J.: Passage of Tyr-MIF-1 from blood to brain. Brain Res. Bull. 23:439-442; 1989.
19. Barrera, C. M.; Kastin, A. J.; Fasold, M. B.; Banks, W. A.: Bidirectional saturable transport of LHRH across the blood-brain barrier. Am. J. Physiol. 261:E312-E318; 1991.
20. Belknap, J. K.; Crabbe, J. C.; Young, E. R.: Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology (Berlin) 112:503-510; 1993.
21. Blum, K.; Elston, S. F. A.; DeLallo, L.; Briggs, A. H.; Wallace, J. E.: Ethanol acceptance as a function of genotype amounts of brain [met]-enkephalin. Proc. Natl. Acad. Sci. USA 80:6510-6512; 1983.
22. Crabbe, J. C.; Gallaher, E. S.; Phillips, T. J.; Belknap, J. K.: Genetic determinants of sensitivity to ethanol in inbred mice. Behav. Neurosci. 108:186-195; 1994.
23. Crabbe, J. C.; Kosobud, A.; Young, E. R.; Janowsky, J. S.: Polygenic and single-gene determination of responses to ethanol in BXD/Ty recombinant inbred mouse strains. Neurobehav. Toxicol. Teratol. 5:181-187; 1983.
24. Durham, D. A.; Banks, W. A.; Kastin, A. J.: Carrier-mediated transport of labeled oxytocin from brain to blood. Neuroendocrinology 53:447-452; 1991.
25. Harrison, L. M.; Zadina, J. E.; Banks, W. A.; Kastin, A. J.: Effects of neonatal treatment with Tyr-MIF-1, morphiceptin, and morphine on development, tail flick, and blood-brain barrier transport. Dev. Brain Res. 75:207-212; 1993.
26. Ho, A. K. S.; Rossi, N.: Suppression of ethanol consumption by MET-enkephalin in rats. J. Pharm. Pharmacol. 34:118-119; 1982.
27. Hong, J. S.; Majchrowicz, E.; Hunt, W. A.; Gillin, J. C: Reduction in cerebral methionine-enkephalin content during the ethanol withdrawal syndrome. Subst. Alcohol Actions Misuse 2:233-240; 1981.
28. Maness, L. M.; Banks, W. A.; Zadina, J. E.; Kastin, A. J.: Periventricular penetration and disappearance of ICV Tyr-MIF-1, DAMGO, tyrosine, and albumin. Peptides 17:247-250; 1996.
29. Medbak, S.; Mason, D. F.; Rees, L. H.: Effect of ethanol and inhibitors of its metabolism on the circulating levels of Metenkephalin in greyhounds. J. Endocrinol. 120:473-480; 1989.
30. Przewlocka, B.; Lason, W.; Przewlocka, R.: Effect of repeated ethanol administration on opioid peptide systems activity in rat hypothalamus and pituitary. Pharm. Res. 25(Suppl. 2):71-72; 1992.
31. 5-enkephalinamide impairs the acquisition of ethanol preference without influencing sucrose preference. Physiol. Behav. 48:435-439; 1990.